# 119-hr-3042: MMEDS Act of 2025

119-hr-3042, MMEDS Act of 2025, is a 119th Congress bill sponsored by Rep. Malliotakis, Nicole [R-NY-11] (R-NY); status introduced; PRIA reads it as touching household money (as of 2026-04-21).

- Canonical: https://policyrisk.com/legislation/119-hr-3042
- As of: 2026-04-21
- Plain-text twin of the page above; the HTML and this file carry the same facts.

## Facts
- Bill: 119-hr-3042
- Congress: 119
- Title: MMEDS Act of 2025
- Status: introduced
- Introduced: 2025-04-28
- Sponsor: Rep. Malliotakis, Nicole [R-NY-11] (R-NY)
- Cosponsors: 10
- Policy area: Taxation
- Touches household money: yes
- Last recorded action: 2026-04-21

## Summary

**This bill would create a targeted program to rebuild and expand U.S. medical manufacturing in economically distressed zones by offering large tax incentives and by prioritizing development of population health products for vulnerable groups.** It focuses on credits for jobs, benefits, capital spending, and onshore supply chains to make medical production more resilient and locally anchored. - Workers in designated economically distressed zones could benefit from employers claiming a credit equal to 40 percent of qualifying EDZ wages, allocable fringe benefits, and depreciation for facility property tied to medical manufacturing. Employers must follow wage limits tied to Social Security contribution rules. - Domestic medical manufacturers would get extra tax breaks for buying EDZ-made inputs and services, with credit rates of 30 percent for purchases from unrelated sellers and 5 percent for related parties. The bill also boosts incentives for repatriated facilities and allows a 100 percent expensing election for certain repatriated property. - Distressed communities and vulnerable populations are central to the plan. EDZs are set by poverty triggers like a 30 percent poverty rate or a 25 percent threshold with additional criteria. The bill also expands federal authority to accelerate R&D, manufacturing, stockpiling, and timely delivery of population health products for at-risk Americans and requires a 90-day report on health disparities and incentives.

## Cosponsors (10)

- Rep. Torres, Ritchie [D-NY-15] (D-NY), 2025-04-28T00:00:00.000Z
- Rep. Salazar, Maria Elvira [R-FL-27] (R-FL), 2025-04-28T00:00:00.000Z
- Rep. Soto, Darren [D-FL-9] (D-FL), 2025-04-28T00:00:00.000Z
- Rep. Hurd, Jeff [R-CO-3] (R-CO), 2025-04-28T00:00:00.000Z
- Rep. Gimenez, Carlos A. [R-FL-28] (R-FL), 2025-05-05T00:00:00.000Z
- Rep. Quigley, Mike [D-IL-5] (D-IL), 2025-05-08T00:00:00.000Z
- Rescom. Hernández, Pablo Jose [D-PR-At Large] (D-PR), 2025-05-08T00:00:00.000Z
- Rep. Buchanan, Vern [R-FL-16] (R-FL), 2025-05-15T00:00:00.000Z
- Rep. Tenney, Claudia [R-NY-24] (R-NY), 2025-06-03T00:00:00.000Z
- Rep. Gooden, Lance [R-TX-5] (R-TX), 2025-06-24T00:00:00.000Z

## Provisions PRIA read

- 100% expensing for onshored medical plants: benefit, high. If enacted, qualifying onshored or population‑health facilities could elect to expense 100% of the cost of certain plant property in the year it is placed in service. If you make this election, you would not count that property’s depreciation in the 40% facility credit, but you could deduct the ful…
- Credit for buying from distressed-area suppliers: benefit, high. If enacted, eligible U.S. medical manufacturers could claim a credit for purchases of products and services made in distressed zones. The base credit would be 30% for purchases from unrelated sellers and 5% for related parties. Higher rates could apply if the facility is an onshored plant moved fro…
- Large tax credit for medical manufacturers: benefit, high. If enacted, medical manufacturers with a qualified facility in a designated distressed zone could get a credit equal to 40% of EDZ wages, certain benefits, and facility depreciation each year. Wages per worker would be capped at the Social Security wage base, and double‑dipping with other similar c…
- Faster development and delivery of population health products: benefit, medium. If enacted, HHS would define and prioritize population health products that protect vulnerable groups such as children, pregnant people, older adults, and minority communities. HHS could focus advanced research, manufacturing, and stockpiling on these products and related platform technologies. Dur…

## Related bills

- 119-hr-9877: Health Equity and Accountability Act of 2026
- 119-hr-1262: Mikaela Naylon Give Kids a Chance Act
- 119-hr-842: Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act
- 119-hr-1993: 25th Anniversary of 9/11 Commemorative Coin Act
- 119-hr-2102: Major Richard Star Act
- 119-hr-2853: Combating Organized Retail Crime Act of 2025

## Sources
- [119-hr-3042 on Congress.gov](https://www.congress.gov/bill/119th-congress/house-bill/3042)

## Related
- [119-hr-9877: Health Equity and Accountability Act of 2026](https://policyrisk.com/legislation/119-hr-9877)
- [119-hr-1262: Mikaela Naylon Give Kids a Chance Act](https://policyrisk.com/legislation/119-hr-1262)
- [119-hr-842: Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage A…](https://policyrisk.com/legislation/119-hr-842)
- [119-hr-1993: 25th Anniversary of 9/11 Commemorative Coin Act](https://policyrisk.com/legislation/119-hr-1993)
- [119-hr-2102: Major Richard Star Act](https://policyrisk.com/legislation/119-hr-2102)
- [119-hr-2853: Combating Organized Retail Crime Act of 2025](https://policyrisk.com/legislation/119-hr-2853)
- [All bills in Congress](https://policyrisk.com/legislation)

Source: PRIA, https://policyrisk.com/legislation/119-hr-3042 (as of 2026-04-21).